x
|
Annual
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
o
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
Delaware
(State
of Incorporation)
|
20-4743916
(Small
Business Issuer
I.R.S.
Employer I.D. Number)
|
825
Third Avenue, 40th Floor, New York, New York
(Address
of principal executive offices)
|
10022
(zip
code)
|
Year
Ending December 31
|
EBITDA
Target
|
Contingent
Shares
|
|||||
2008
|
$
|
39.3
million
|
2.5
million
|
||||
2009
|
$
|
46.0
million
|
2.5
million
|
Units
|
Common
Stock
|
Warrants
|
|||||||||||||||||
High
|
Low
|
High
|
Low
|
High
|
Low
|
||||||||||||||
2008:
|
|||||||||||||||||||
Second
Quarter*
|
11.10
|
10.08
|
8.00
|
7.80
|
3.03
|
2.05
|
|||||||||||||
First
Quarter
|
10.70
|
8.70
|
7.99
|
7.56
|
2.67
|
1.10
|
|||||||||||||
2007:
|
|||||||||||||||||||
Fourth
Quarter
|
9.35
|
8.80
|
7.54
|
7.43
|
1.65
|
1.30
|
|||||||||||||
Third
Quarter
|
9.15
|
8.65
|
7.50
|
7.37
|
1.52
|
1.25
|
|||||||||||||
Second
Quarter
|
8.95
|
8.60
|
7.42
|
7.28
|
1.51
|
1.30
|
|||||||||||||
First
Quarter
|
9.00
|
8.60
|
7.51
|
7.30
|
1.49
|
1.18
|
|||||||||||||
2006:
|
|||||||||||||||||||
Fourth
Quarter
|
8.50
|
7.96
|
7.25
|
7.10
|
1.25
|
0.78
|
Stockholders
|
Number
of Shares
|
|||
Eric
S. Rosenfeld
|
765,000
|
|||
Rosenfeld
1991 Children’s Trust
|
106,840
|
|||
|
||||
Arnaud
Ajdler
|
50,632
|
|||
Leonard
B. Schlemm
|
40,632
|
|||
Jon
Bauer
|
40,632
|
|||
Colin
D. Watson
|
40,632
|
|||
Joel
Greenblatt
|
40,632
|
|||
David
D. Sgro, CFA
|
20,000
|
|||
Greg
Monahan
|
20,000
|
Payment
due by period
|
||||||||||||||||
Contractual
Obligations
|
Total
|
Less
than
1
year
|
1-3
years
|
3-5
years
|
More than
5
years
|
|||||||||||
Administrative
services agreement
|
$
|
68,226
|
$
|
68,226
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||
Payments
to data service provider
|
16,256
|
16,256
|
-
|
-
|
-
|
|||||||||||
Fee
due to investment banker on completion of business
combination
|
414,000
|
414,000
|
-
|
-
|
-
|
|||||||||||
Total
|
$
|
498,482
|
$
|
498,482
|
$
|
-
|
$
|
-
|
$
|
-
|
Name
|
Age
|
Position
|
||
Eric
S. Rosenfeld
|
50
|
Chairman
of the Board, Chief Executive Officer and President
|
||
David
D. Sgro, CFA
|
31
|
Chief
Financial Officer
|
||
Arnaud
Ajdler
|
32
|
Secretary
and Director
|
||
Leonard
B. Schlemm
|
55
|
Director
|
||
Jon
Bauer
|
50
|
Director
|
||
Colin
D. Watson
|
66
|
Director
|
· |
each
person known by us to be the beneficial owner of more than 5%
of our
outstanding shares of common
stock;
|
· |
each
of our officers and directors; and
|
· |
all
our officers and directors as a
group.
|
Beneficial
Ownership of Our Common
Stock
on May 27, 2008
|
|||||||
Name
And Address of Beneficial Owner(1)
|
Number
of Shares
|
Percent
of Class
|
|||||
Eric
S. Rosenfeld
|
871,840
|
(2)
|
13.8
|
%
|
|||
Arnaud
Ajdler
|
50,632
|
*
|
|||||
Leonard
B. Schlemm(3)
|
40,632
|
(4)
|
*
|
||||
Jon
Bauer
(5)
|
40,632
|
(4)
|
*
|
||||
Colin
D. Watson(6)
|
40,632
|
(4)
|
*
|
||||
Millennium
Management, L.L.C.(7)
|
627,500
|
(8)
|
9.9
|
%
|
|||
Fir
Tree, Inc.(9)
|
600,125
|
(10)
|
9.5
|
%
|
|||
Dorset
Management Corporation(11)
|
385,000
|
(12)
|
6.1
|
%
|
|||
D.B.
Zwirn & Co., L.P.(13)
|
323,500
|
(14)
|
5.1
|
%
|
|||
QVT
Financial LP(15)
|
554,462
|
(16)
|
8.8
|
%
|
|||
David
D. Sgro
|
20,000
|
*
|
|||||
All
Current Directors And Executive Officers As A Group (6
Individuals)
|
1,064,368
|
(17)
|
16.9
|
%
|
(1)
|
Unless
otherwise indicated, the business address of each of the individuals
is
825 Third Avenue, 40th Floor, New York, New York
10022.
|
(2)
|
Includes
106,840 shares of common stock held by the Rosenfeld 1991 Children’s
Trust, of which Mr. Rosenfeld’s wife is the sole trustee. Does not include
863,636 shares of common stock issuable upon exercise of warrants
held by
Mr. Rosenfeld that are not exercisable and will not become exercisable
within 60 days.
|
(3)
|
The
business address of Mr. Schlemm is c/o The Atwater Club, 3505 Avenue
Atwater, Montreal, Quebec H3W 1Y2.
|
(4)
|
Does
not include 68,182 shares of common stock issuable upon exercise
of
warrants held by such individual that are not exercisable and will
not
become exercisable within 60 days.
|
(5)
|
The
business address of Mr. Bauer is 411 W. Putnam Ave., Ste 225, Greenwich,
Connecticut 06830.
|
(6)
|
The
business address of Mr. Watson is 72 Chestnut Park Rd., Toronto,
Ontario,
M4W 1W8.
|
(7)
|
The
business address of Millennium Management, L.L.C. is 666 Fifth Avenue,
New
York, New York 10103.
|
(8)
|
Represents
627,500 shares of common stock held by Millenco, L.L.C. Does not
include
896,137 shares of common stock issuable upon exercise of warrants
held by
Millenco, L.L.C. that are not exercisable and will not become exercisable
within 60 days. Millennium Management, L.L.C. is the manager of Millenco,
L.L.C. Israel A. Englander is the managing member of Millennium
Management. The foregoing information was derived from a Schedule
13G/A
filed with the SEC on February 7,
2008.
|
(9) |
The
business address of Fir Tree, Inc. is 505 Fifth Avenue, 23rd Floor,
New
York, New York 10017.
|
(10)
|
Represents
(i) 531,405 shares of common stock held by Sapling, LLC and (ii)
68,720
shares of common stock held by Fir Tree Recovery Master Fund, L.P.
Fir
Tree, Inc. is the investment manager of both entities. Jeff Tannenbaum
is
the president of each of Fir Tree, Inc. and Fir Tree Recovery Master
Fund,
L.P. The foregoing information was derived from a Schedule 13G/A
filed
with the SEC on February 14, 2008.
|
(11)
|
The
business address of Dorset Management Corporation is 485 Underhill
Boulevard, Suite 205, Syosset, New York
11791.
|
(12)
|
Represents
shares beneficially held by David M. Knott and Dorset Management
Corporation, as reported in a Schedule 13G/A filed with the SEC on
February 14, 2007.
|
(13)
|
The
business address of D.B. Zwirn & Co., L.P. is 745 Fifth Avenue, 18th
Floor, New York, New York 10151.
|
(14)
|
Represents
(i) 130,321 shares of common stock owned by D.B. Zwirn Opportunities
Fund,
L.P. and (ii) 193,179 shares of common stock owned by D.B. Zwirn
Special
Opportunities Fund, Ltd. D.B. Zwirn & Co., L.P. is the manager of the
funds. The foregoing information was derived from a Schedule 13G/A
filed
with the SEC on February 5, 2008.
|
(15)
|
The
business address of QVT Financial LP is 1177 Avenue of the Americas,
9th
Floor, New York, New York 10036.
|
(16)
|
Represents
(i) 471,207 shares of common stock owned by QVT Fund LP, (ii) 51,751
shares of common stock owned by Quintessence Fund L.P. and (iii)
31,504
shares held by Deutsche Bank AG. QVT Financial LP is the investment
manager of each of these funds. The foregoing information was derived
from
a Schedule 13G/A filed with the SEC on February 7,
2008.
|
(17)
|
Does
not include 1,068,182 shares of common stock issuable upon exercise
of
warrants held by such individuals that are not exercisable and will
not
become exercisable within 60 days.
|
Name
|
Number of Shares
|
Relationship to Us
|
||
Eric
S. Rosenfeld
|
765,000
|
Chairman
of the Board, Chief Executive Officer and President
|
||
Rosenfeld
1991 Children’s Trust
|
106,840
|
Trustee
is wife of Chairman of the Board, Chief Executive Officer and
President
|
||
Arnaud
Ajdler
|
50,632
|
Secretary
and Director
|
||
Leonard
B. Schlemm
|
40,632
|
Director
|
||
Jon
Bauer
|
40,632
|
Director
|
||
Colin
D. Watson
|
40,632
|
Director
|
||
Joel
Greenblatt
|
40,632
|
Special
Advisor
|
||
David
D. Sgro, CFA
|
20,000
|
Chief
Financial Officer
|
||
Greg
Monahan
|
20,000
|
Stockholder
|
·
|
each
agreed to vote all Founder Shares owned by him in accordance with
the
majority of the IPO Shares if we solicit approval of our stockholders
for
a business combination;
|
·
|
if
we fail to consummate a business combination by October 3, 2008,
each
agreed to take all reasonable actions within his power to cause us
to
liquidate as soon as reasonably
practicable;
|
·
|
each
waived any and all rights he may have to receive any distribution
of cash,
property or other assets as a result of such liquidation with respect
to
his Founder Shares;
|
·
|
each
agreed to present to us for our consideration, prior to presentation
to
any other person or entity, any suitable opportunity to acquire an
operating business, until the earlier of our consummation of a business
combination, our liquidation or until such time as he ceases to be
an
officer or director of ours, subject to any pre-existing fiduciary
obligations he might have;
|
·
|
each
agreed that we could not consummate any business combination which
involves a company which is affiliated with any of the Founders
unless
we obtain an opinion from an independent investment banking firm
reasonably acceptable to EarlyBirdCapital that the business combination
is
fair to our stockholders from a financial
perspective;
|
·
|
each
agreed that he and his affiliates will not be entitled to receive
and will
not accept any compensation for services rendered to us prior to,
or in
connection with, the consummation of our business combination;
and
|
·
|
each
agreed that he and his affiliates will not be entitled to receive
or
accept a finder’s fee or any other compensation in the event he or his
affiliates originate a business
combination.
|
Description
|
|||
2.1
|
Agreement
and Plan of Merger dated as of February 19, 2008 by and among Rhapsody
Acquisition Corp., Primoris Corporation and certain shareholders
of
Primoris Corporation. (1)
|
||
3.1
|
Amended
and Restated Certificate of Incorporation. (2)
|
||
3.2
|
By-laws.
(2)
|
||
4.1
|
Specimen
Unit Certificate. (2)
|
||
4.2
|
Specimen
Common Stock Certificate. (2)
|
||
4.3
|
Specimen
Warrant Certificate. (2)
|
||
4.4
|
Form
of Unit Purchase Option to be granted to Representative.
(2)
|
||
4.5
|
Form
of Warrant Agreement between Continental Stock Transfer & Trust
Company and the Registrant. (2)
|
||
10.1
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Eric S.
Rosenfeld. (2)
|
||
10.2
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Arnaud
Ajdler.
(2)
|
||
10.3
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Leonard
B.
Schlemm. (2)
|
||
10.4
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Jon Bauer.
(2)
|
||
10.5
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Colin
D.
Watson. (2)
|
||
10.6
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and David
D. Sgro,
CFA. (2)
|
||
10.7
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Greg Monahan.
(2)
|
||
10.8
|
Letter
Agreement among the Registrant, EarlyBirdCapital, Inc. and Joel
Greenblatt. (2)
|
||
10.9
|
Form
of Investment Management Trust Agreement between Continental Stock
Transfer & Trust Company and the Registrant. (2)
|
||
10.10
|
Form
of Stock Escrow Agreement between the Registrant, Continental Stock
Transfer & Trust Company and the Initial Stockholders.
(2)
|
10.11
|
Form
of Letter Agreement between Crescendo Advisors II LLC and Registrant
regarding administrative support. (2)
|
||
10.12
|
Form
of Registration Rights Agreement among the Registrant and the Initial
Stockholders. (2)
|
||
10.13
|
Form
of Subscription Agreement among the Registrant, Graubard Miller and
each
of Eric S. Rosenfeld, Leonard B. Schlemm, Jon Bauer, Colin D. Watson
and
Gotham Capital V. (2)
|
||
10.14
|
Form
of Escrow Agreement among Rhapsody Acquisition Corp., Brian Pratt,
as
Representative, and Continental Stock Transfer & Trust Company, as
Escrow Agent. (1)
|
||
10.15
|
Form
of Employment Agreement. (1)
|
||
10.16
|
Form
of Voting Agreement. (1)
|
||
10.17
|
2008
Long-Term Equity Incentive Plan. (1)
|
||
10.18
|
Form
of Lock-Up Agreement by and among Rhapsody Acquisition Corp. and
the
Primoris Stockholders. (1)
|
||
31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
||
31.2
|
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
||
32
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to
Section
906 of the Sarbanes-Oxley Act of
2002.
|
Incorporated
by reference to the Registrant’s Registration Statement on Form S-4 (SEC
File No. 333-150343)
|
||
(2)
|
Incorporated
by reference to the Registrant’s Registration Statement on Form S-1 (SEC
File No. 333-134694)
|
Report
of Independent Registered Public Accounting Firm
|
|
F-2
|
Financial
statements
|
|
|
Balance
Sheets
|
|
F-3
|
Statements
of Operations
|
|
F-4
|
Statement
of Stockholders’ Equity
|
|
F-5
|
Statements
of Cash Flows
|
|
F-6
|
Summary
of Significant Accounting Policies
|
|
F-7
|
Notes
to Financial Statements
|
|
F-10
|
|
March
31,
2008
|
March
31,
2007
|
|||||
ASSETS
|
|||||||
Current
Assets:
|
|||||||
Cash
and cash equivalents
|
$
|
69,123
|
$
|
515,240
|
|||
Cash
and cash equivalents held in Trust Fund, including interest (Note
2)
|
41,049,635
|
39,922,072
|
|||||
Prepaid
expenses and other
|
5,367
|
63,940
|
|||||
Total
current assets
|
41,124,125
|
40,501,252
|
|||||
Total
assets
|
$
|
41,124,125
|
$
|
40,501,252
|
|||
Current
liabilities:
|
|||||||
Accrued
expenses and taxes (Note 4)
|
$
|
213,802
|
$
|
41,491
|
|||
Deferred
underwriting fee (Note 2)
|
414,000
|
414,000
|
|||||
Total
current liabilities
|
$
|
627,802
|
$
|
455,491
|
|||
Common
Stock, subject to possible conversion (1,034,483 shares at conversion
value) (Note 2)
|
$
|
8,205,826
|
$
|
7,980,426
|
|||
Preferred
stock, $.0001 par value, 1,000,000 shares authorized, 0 shares
issued
|
-
|
-
|
|||||
Common
stock, $.0001 par value, 15,000,000 shares authorized, 5,265,517
shares
issued and outstanding (excluding 1,034,483 shares subject to possible
conversion)
|
527
|
527
|
|||||
Additional
paid-in capital
|
31,488,306
|
31,713,706
|
|||||
801,664
|
351,102
|
||||||
Total
stockholders’ equity
|
32,290,497
|
32,065,335
|
|||||
$
|
41,124,125
|
$
|
40,501,252
|
|
Twelve
Months
Ended
March
31,
2008
|
Period
from
April
24,
2006
(inception)
to
March
31,
2007
|
Period
from
April
24,
2006
(inception)
to
March
31,
2008
|
|||||||
Operating
expenses:
|
||||||||||
General
and administrative costs (Notes 4 and 7)
|
$
|
500,166
|
$
|
229,999
|
$
|
730,165
|
||||
Transaction
related expenses (Note 8)
|
222,924
|
-
|
222,924
|
|||||||
Operating
loss
|
(723,090
|
)
|
(229,999
|
)
|
(953,089
|
)
|
||||
Other
Income:
|
||||||||||
Interest
income
|
6,134
|
10,233
|
16,367
|
|||||||
Interest
on Trust Fund
|
1,327,563
|
643,822
|
1,971,385
|
|||||||
Net
income before provision for income taxes
|
610,607
|
424,056
|
1,034,663
|
|||||||
Provision
for income taxes (Note 7)
|
(160,045
|
)
|
(72,954
|
)
|
(232,999
|
)
|
||||
Net
Income
|
$
|
450,562
|
$
|
351,102
|
$
|
801,664
|
||||
Accretion
of Trust Fund relating to common stock subject to
possible conversion
|
(225,400
|
)
|
(128,700
|
)
|
(354,100
|
)
|
||||
Net
income attributable to common stockholders
|
$
|
225,162
|
$
|
222,402
|
$
|
447,564
|
||||
Common
shares outstanding subject to possible conversion
|
1,034,483
|
1,034,483
|
||||||||
Basic
and diluted net income per share subject to possible
conversion
|
$
|
0.22
|
$
|
0.12
|
||||||
Weighted
average common shares outstanding
|
5,265,517
|
3,213,472
|
||||||||
Basic
and diluted net income per share
|
$
|
0.04
|
$
|
0.07
|
Common
Stock
|
Additional
paid-in
|
Retained
Earnings
Accumulated During the Development
|
Stockholders’
|
|||||||||||||
|
Shares
|
Amount
|
capital
|
Stage
|
Equity
|
|||||||||||
Balance,
April 24, 2006
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
|||||||
Common
shares issued to initial stockholders
|
1,125,000
|
113
|
24,887
|
-
|
25,000
|
|||||||||||
Sale
of 5,175,000 units, net of underwriter's discount and offering
expenses
(includes 1,034,483 shares subject to possible conversion)
|
5,175,000
|
517
|
38,419,042
|
-
|
38,419,559
|
|||||||||||
Net
proceeds subject to possible conversion (1,034,483 shares)
|
(1,034,483
|
)
|
(103
|
)
|
(7,851,623
|
)
|
-
|
(7,851,726
|
)
|
|||||||
Proceeds
from issuance of underwriter's purchase option
|
-
|
-
|
100
|
-
|
100
|
|||||||||||
Proceeds
from issuance of insider warrants
|
-
|
-
|
1,250,000
|
-
|
1,250,000
|
|||||||||||
Accretion
of trust fund relating to common stock subject to possible
conversion
|
-
|
-
|
(128,700
|
)
|
-
|
(128,700
|
)
|
|||||||||
Net
income from inception through March 31, 2007
|
-
|
-
|
-
|
351,102
|
351,102
|
|||||||||||
Balance
at March 31, 2007
|
5,265,517
|
$
|
527
|
$
|
31,713,706
|
$
|
351,102
|
$
|
32,065,335
|
|||||||
Accretion
of trust fund relating to common stock subject to possible conversion
|
-
|
-
|
(225,400
|
)
|
-
|
(225,400
|
)
|
|||||||||
Net
income for the year
|
-
|
-
|
-
|
450,562
|
450,562
|
|||||||||||
Balance
at March 31, 2008
|
5,265,517
|
$
|
527
|
$
|
31,488,306
|
$
|
801,664
|
$
|
32,290,497
|
Twelve
Months Ended
March
31, 2008
|
Period
from
April
24, 2006 (inception) to
March
31,
2007
|
Period
from
April
24, 2006 (inception) to
March
31,
2008
|
||||||||
OPERATING
ACTIVITIES
|
||||||||||
Net
Income for the period
|
$
|
450,562
|
$
|
351,102
|
$
|
801,664
|
||||
Adjustments
to reconcile net income to net cash used in operating
activities:
|
||||||||||
Trust
Fund Interest Income
|
(1,327,563
|
)
|
(643,822
|
)
|
(1,971,385
|
)
|
||||
Change
in operating assets and liabilities:
|
||||||||||
(Increase)
Decrease in prepaid expenses & other
|
58,573
|
(63,940
|
)
|
(5,367
|
)
|
|||||
Increase
(Decrease) in accrued expenses and taxes
|
172,311
|
41,491
|
213,802
|
|||||||
Net
cash provided by (used in) operating activities
|
$
|
(646,117
|
)
|
$
|
(315,169
|
)
|
$
|
(961,286
|
)
|
|
INVESTING
ACTIVITIES
|
||||||||||
(Cash
contributions to) distributions from the Trust Fund
|
200,000
|
(39,278,250
|
)
|
(39,078,250
|
)
|
|||||
Net
cash provided by (used in) investing activities
|
$
|
200,000
|
$
|
(39,278,250
|
)
|
$
|
(39,078,250
|
)
|
||
FINANCING
ACTIVITIES
|
||||||||||
Proceeds
from sale of shares of common stock to initial
stockholders
|
-
|
25,000
|
25,000
|
|||||||
Proceeds
from note payable, stockholder
|
-
|
90,000
|
90,000
|
|||||||
Repayment
of note payable, stockholder
|
-
|
(90,000
|
)
|
(90,000
|
)
|
|||||
Proceeds
from sale of underwriters' purchase option
|
-
|
100
|
100
|
|||||||
Proceeds
from issuance of insider warrants
|
-
|
1,250,000
|
1,250,000
|
|||||||
Portion
of proceeds from sale of units through public offering, subject to
possible conversion
|
-
|
7,851,726
|
7,851,726
|
|||||||
Net
proceeds from sale of units through public offering allocable to
stockholders' equity
|
-
|
30,981,833
|
30,981,833
|
|||||||
Net
cash provided by financing activities
|
$
|
-
|
$
|
40,108,659
|
$
|
40,108,659
|
||||
Net
increase in cash and cash equivalents
|
$
|
(446,117
|
)
|
$
|
515,240
|
$
|
69,123
|
|||
Cash
and cash equivalents at beginning of period
|
515,240
|
-
|
-
|
|||||||
Cash
and cash equivalents at end of period
|
$
|
69,123
|
$
|
515,240
|
$
|
69,123
|
||||
Supplemental
disclosure of non-cash financing activities
|
||||||||||
Fair
value of underwriter purchase option included in offering
costs
|
$
|
-
|
$
|
1,687,500
|
$
|
1,687,500
|
||||
Deferred
underwriting fee
|
$
|
-
|
$
|
414,000
|
$
|
414,000
|
||||
Accretion
of trust account relating to common stock subject to
conversion
|
$
|
225,400
|
$
|
128,700
|
$
|
354,100
|
||||
Cash
paid for taxes
|
$
|
117,487
|
$
|
65,000
|
$
|
182,487
|
Income
taxes
|
The
Company follows Statement of Financial Accounting Standards No. 109
(“SFAS
No. 109”), “Accounting for Income Taxes” which is an asset and liability
approach that requires the recognition of deferred tax assets and
liabilities for the expected future tax consequences of events that
have
been recognized in the Company’s financial statements or tax
returns.
|
Net
income per
common
share
|
Basic
earnings (loss) per share excludes dilution and is computed by dividing
income (loss) available to common stockholders by the weighted average
common shares outstanding for the period. Net income per share subject
to
possible conversion is calculated by dividing accretion of trust
account
relating to common stock subject to possible conversion by 1,034,483
common stock subject to possible conversion. Diluted earnings per
share
reflects the potential dilution that could occur if securities or
other
contracts to issue common stock were exercised or converted into
common
stock or resulted in the issuance of common stock that then shared
in the
earnings of the entity. At March 31, 2008, there were no such potentially
dilutive securities.
|
Use
of estimates
|
The
preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period.
Actual
results could differ from those estimates.
|
Cash
and cash
equivalents
|
The
Company considers all highly liquid investments with original maturities
of three months or less to be cash equivalents.
|
Concentration
of
credit
risk
|
Financial
instruments that potentially subject the Company to a significant
concentration of credit risk consist primarily of cash and cash
equivalents. The Company maintains deposits in federally insured
financial
institutions in excess of federally insured limits. However, management
believes the Company is not exposed to significant credit risk due
to the
financial position of the depository institutions in which those
deposits
are held.
|
Transaction
Costs
|
Costs
related to proposed mergers are capitalized and in the event the
merger
does not occur or if the merger is to be accounted for as a reverse
acquisition, the costs are expensed. As of March 31, 2008, the Company
has
expensed merger costs as the proposed transaction disclosed in Note
8 will
be treated as a reverse acquisition.
|
Recently
issued
accounting
standards
|
In
June 2006, the Financial Accounting Standards Board (“FASB”) issued
Interpretation No. 48 (“FIN 48”), “Accounting for Uncertainty in Income
Taxes, and Interpretation of FASB Statement No. 109.” FIN 48 clarifies the
accounting for uncertainty in income taxes recognized in a company’s
financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and
measurement of a tax position taken or expected to be taken in an
income
tax return. FIN 48 also provides guidance in classification, interest
and
penalties, accounting in interim periods, disclosures and transition.
FIN
48 is effective for the fiscal years beginning after December 15,
2006.
The adoption of FIN 48 did not have a material impact on the Company’s
financial statements.
|
In
September 2006, the FASB issued FASB Statement No. 157, Fair Value
Measurements “SFAS No. 157”), which defines fair value, establishes a
framework for measuring fair value under GAAP, and expands disclosures
about fair value measurements. SFAS No. 157 applies to other accounting
pronouncements that require or permit fair value measurements. The
new
guidance is effective for financial statements issued for fiscal
years
beginning after November 15, 2007, and for interim periods within
those
fiscal years. The Company will evaluate the potential impact, if
any, of
the adoption of SFAS No. 157 on its financial position, results of
operations and cash flows.
In
December 2007, the FASB issued SFAS 141, Business
Combinations, (“SFAS
141(R)”). SFAS 141(R) retains the fundamental requirements of the original
pronouncement requiring that the purchase method be used for all
business
combinations, but also provides revised guidance for recognizing
and
measuring identifiable assets and goodwill acquired and liabilities
assumed arising from contingencies, the capitalization of in-process
research and development at fair value, and the expensing of
acquisition-related costs as incurred. SFAS 141(R) is effective for
fiscal
years beginning after December 15, 2008. In the event that the Company
completes acquisitions subsequent to its adoption of SFAS 141 (R),
the
application of its provisions will likely have a material impact
on the
Company’s results of operations, although the Company is not currently
able to estimate that impact.
In
December 2007, the FASB issued SFAS 160, Noncontrolling
Interests in Consolidated Financial Statements –
an
amendment of ARB No. 51. SFAS
160 requires that ownership interests in subsidiaries held by parties
other than the parent, and the amount of consolidated net income,
be
clearly identified, labeled and presented in the consolidated financial
statements. It also requires once a subsidiary is deconsolidated,
any
retained noncontrolling equity investment in the former subsidiary
be
initially measured at fair value. Sufficient disclosures are required
to
clearly identify and distinguish between the interests of the parent
and
the interests of the noncontrolling owners. It is effective for fiscal
years beginning after December 15, 2008, and requires retroactive
adoption
of the presentation and disclosure requirements for existing minority
interests. All other requirements are applied prospectively. The
Company
does not expect the adoption of SFAS 160 to have a material impact
on its
financial condition or results of operations.
|
Management
does not believe that any other recently issued, but not yet effective,
accounting standards if currently adopted would have a material effect
on
the Company’s consolidated financial
statements.
|
1. |
Basis
of Presentation
|
2. |
Organization
and Business Operations
|
3. |
Initial
Public Offering
|
4. |
Commitments
|
5. |
Preferred
Stock
|
6. |
Common
Stock
|
7. |
Income
Taxes
|
8. |
Proposed
Merger
|
Year
Ending December 31
|
EBITDA Target
|
Contingent Shares
|
|||||
2008
|
$
|
39.3
million
|
2.5
million
|
||||
2009
|
$
|
46.0
million
|
2.5
million
|
RHAPSODY ACQUISITION CORP. | ||
By:
|
/s/
Eric S. Rosenfeld
|
|
Eric
S. Rosenfeld
|
||
Chairman,
Chief Executive Officer and President
|
Name
|
Title
|
Date
|
||
/s/
Eric S. Rosenfeld
|
Chairman
of the Board, Chief
Executive
Officer and President
|
May
30, 2008
|
||
Eric
S. Rosenfeld
|
(Principal
Executive Officer)
|
|||
/s/
David D. Sgro
|
Chief
Financial Officer (Principal
|
May
30, 2008
|
||
David
D. Sgro
|
Accounting
and Financial Officer)
|
|||
/s/
Arnaud Ajdler
|
Secretary
and Director
|
May
30, 2008
|
||
Arnaud
Ajdler
|
||||
/s/
Leonard B. Schelmm
|
Director
|
May
30, 2008
|
||
Leonard
B. Schlemm
|
||||
/s/
Jon Bauer
|
Director
|
May
30, 2008
|
||
Jon
Bauer
|
||||
/s/
Colin D. Watson
|
Director
|
May
30, 2008
|
||
Colin
D. Watson
|